Singapore: Novotech expands global expertise with acquisition of NCGS

Leading Asia-Pacific biotech specialist CRO, Novotech, has acquired US CRO NCGS as part of its expansion programme. NCGS, established in 1984 in South Carolina, is a privately held CRO with a biopharma client base and a workforce of about 300 professionals across the US. It focuses on complex areas of clinical development; oncology, hematology, infectious…

You must be a HMI Subscriber to view this content.

Subscribe Now »